Company intelligence / Profile preview

Triple W

Ownership: Private
Development stage: Commercial

Overview

Triple W develops and markets DFree, a wearable ultrasound device that monitors bladder volume to help manage urinary incontinence. The device provides real-time notifications to users or caregivers when it’s time to go to the bathroom. Clinical studies have demonstrated its utility in improving quality of life for elderly patients and those with mobility challenges by reducing accidents and supporting continence care.

Therapeutic areas: Nephrology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Collaborations with eldercare facilitiesHospitalsDistributors of medical devices

Beyond the preview

Go deeper on Triple W.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triple W.

Explore the full profile